Global Custom Oligonucleotide Synthesis and Gene Synthesis Market Growth (Status and Outlook) 2024-2030

Global Custom Oligonucleotide Synthesis and Gene Synthesis Market Growth (Status and Outlook) 2024-2030

DNA synthesis is the natural or artificial creation of deoxyribonucleic acid (DNA) molecules. DNA is a macromolecule made up of nucleotide units, which are linked by covalent bonds and hydrogen bonds, in a repeating structure.

The global Custom Oligonucleotide Synthesis and Gene Synthesis market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “Custom Oligonucleotide Synthesis and Gene Synthesis Industry Forecast” looks at past sales and reviews total world Custom Oligonucleotide Synthesis and Gene Synthesis sales in 2022, providing a comprehensive analysis by region and market sector of projected Custom Oligonucleotide Synthesis and Gene Synthesis sales for 2023 through 2029. With Custom Oligonucleotide Synthesis and Gene Synthesis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Custom Oligonucleotide Synthesis and Gene Synthesis industry.

This Insight Report provides a comprehensive analysis of the global Custom Oligonucleotide Synthesis and Gene Synthesis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Custom Oligonucleotide Synthesis and Gene Synthesis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Custom Oligonucleotide Synthesis and Gene Synthesis market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Custom Oligonucleotide Synthesis and Gene Synthesis and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Custom Oligonucleotide Synthesis and Gene Synthesis.

United States market for Custom Oligonucleotide Synthesis and Gene Synthesis is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Custom Oligonucleotide Synthesis and Gene Synthesis is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Custom Oligonucleotide Synthesis and Gene Synthesis is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Custom Oligonucleotide Synthesis and Gene Synthesis players cover Genescript, Thermo Fisher Scientific, IDT, Eurofins Genomics, DNA 2.0 (ATUM), etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Custom Oligonucleotide Synthesis and Gene Synthesis market by product type, application, key players and key regions and countries.

Segmentation by Type:
Oligonucleotide Synthesis
Gene Synthesis

Segmentation by Application:
Commercial
Academic Research

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
Oligonucleotide Synthesis
Gene Synthesis

Segmentation by Application:
Commercial
Academic Research

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Genescript
Thermo Fisher Scientific
IDT
Eurofins Genomics
DNA 2.0 (ATUM)
BBI
Azenta Life Sciences
SBS Genetech
Bio Basic
Twist Bioscience
OriGene
Bioneer
Eton Bioscience
Synbio Technologies
Eurogentec

Please note: The report will take approximately 2 business days to prepare and deliver.